132 related articles for article (PubMed ID: 37594592)
1. Is the One-Compartment Model with First Order Absorption a Useful Approximation?
Weiss M
Pharm Res; 2023 Sep; 40(9):2147-2153. PubMed ID: 37594592
[TBL] [Abstract][Full Text] [Related]
2. Dependence of Bioavailability on Mean Absorption Time: What Does It Tell Us?
Weiss M; Siegmund W
AAPS J; 2023 Apr; 25(3):36. PubMed ID: 37016156
[TBL] [Abstract][Full Text] [Related]
3. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
Weiss M
Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.
Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH
Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000
[TBL] [Abstract][Full Text] [Related]
5. The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination.
Garrett ER
J Pharmacokinet Biopharm; 1994 Apr; 22(2):103-28. PubMed ID: 7815308
[TBL] [Abstract][Full Text] [Related]
6. Empirical models for fitting of oral concentration time curves with and without an intravenous reference.
Weiss M
J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):193-201. PubMed ID: 28150181
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of empirical metrics of rate of absorption in bioequivalence studies.
Ring A; Tothfalusi L; Endrenyi L; Weiss M
Pharm Res; 2000 May; 17(5):583-8. PubMed ID: 10888310
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline.
Yu Z; Hwang SS; Gupta SK
Biopharm Drug Dispos; 1997 Aug; 18(6):475-87. PubMed ID: 9267681
[TBL] [Abstract][Full Text] [Related]
11. Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equation.
Volosov A; Bialer M
Biopharm Drug Dispos; 1999 Jan; 20(1):3-9. PubMed ID: 10086832
[TBL] [Abstract][Full Text] [Related]
12. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis.
Wade JR; Kelman AW; Howie CA; Whiting B
J Pharmacokinet Biopharm; 1993 Apr; 21(2):209-22. PubMed ID: 8229681
[TBL] [Abstract][Full Text] [Related]
13. Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.
Olsson Gisleskog PO; Perez Ruixo JJ; Westin Å; Hansson AC; Soons PA
Clin Pharmacokinet; 2021 Apr; 60(4):541-561. PubMed ID: 33354734
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic modelling of tramadol using inverse Gaussian function for the assessment of drug absorption from prolonged and immediate release formulations.
Brvar N; Mateović-Rojnik T; Grabnar I
Int J Pharm; 2014 Oct; 473(1-2):170-8. PubMed ID: 25014367
[TBL] [Abstract][Full Text] [Related]
15. The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.
Csajka C; Drover D; Verotta D
Pharm Res; 2005 Aug; 22(8):1227-35. PubMed ID: 16078132
[TBL] [Abstract][Full Text] [Related]
16. Application of the Loo-Riegelman absorption method.
Wagner JG
J Pharmacokinet Biopharm; 1975 Feb; 3(1):51-67. PubMed ID: 1127578
[TBL] [Abstract][Full Text] [Related]
17. Center of gravity of drug level curves: a model-independent parameter useful in bioavailability studies.
Veng-Pedersen P; Tillman LG
J Pharm Sci; 1989 Oct; 78(10):848-54. PubMed ID: 2600792
[TBL] [Abstract][Full Text] [Related]
18. Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients.
Peng B; Boddy AV; Cole M; Pearson AD; Chatelut E; Rubie H; Newell DR
Eur J Cancer; 1995 Oct; 31A(11):1804-10. PubMed ID: 8541105
[TBL] [Abstract][Full Text] [Related]
19. Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.
Preston SL; Drusano GL; Berman AL; Fowler CL; Chow AT; Dornseif B; Reichl V; Natarajan J; Wong FA; Corrado M
Antimicrob Agents Chemother; 1998 May; 42(5):1098-104. PubMed ID: 9593134
[TBL] [Abstract][Full Text] [Related]
20. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
